Tag: TOT BIOPHARM International Company Limited
TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million
CDMO Business Achieves Leapfrog BreakthroughTwo Products Approved for LaunchSmooth Progress of Various Core Anti-tumor Drugs Clinical TrialsTo Allocate Resources to Boost Innovative...